Tenaya Therapeutics prices $60M public offering of 50M units at $1.20/unit; warrants at $1.50

Tenaya Therapeutics, Inc.

Gross proceeds ~$60M from 50M units, each unit = 1 share + 1 warrant (5-yr, $1.50 exercise).
Underwriters: Leerink Partners, Piper Sandler, LifeSci Capital. Closing expected Dec 15, 2025.
Proceeds to fund development of TN-201 and TN-401 and for working capital and general purposes.
Warrant coverage at 100%; shares and warrants immediately separable on issuance.
60-day lockup for officers, directors, and certain stockholders unless consent is given.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.